Fractyl Health Inc. (GUTS)
Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data ShowingRevita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data ShowingRevita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
There are no comments here yet...